结合多参数MRI与临床特征的简易便捷模型预测乳腺癌肿瘤浸润淋巴细胞
本回顾性研究纳入172例乳腺癌患者,基于多参数MRI与临床特征建立ALSE模型(ADC、临床腋窝淋巴结状态、肿瘤大小、强化模式)无创预测肿瘤浸润淋巴细胞水平;高TIL与更好的无病生存相关,尤其在HER2阳性及三阴性乳腺癌中。
要点
- ALSE模型由ADC、临床腋窝淋巴结状态、肿瘤大小和强化模式构成,用于无创预测TIL水平。
- 高TIL组(≥10%)无病生存优于低TIL组(<10%),p=0.016。
- 高TIL与更长DFS的关联在HER2阳性和三阴性乳腺癌中尤为明显。
核心结论
- 基于多参数MRI和临床特征的ALSE模型可无创预测乳腺癌TIL水平,高TIL与更长DFS相关,尤其在HER2阳性和三阴性乳腺癌中。
研究设计与样本
- 回顾性研究,纳入2017年11月至2021年6月间172例乳腺癌患者,按TIL≥10%和<10%分为高、低TIL组,由两名放射科医师评估MRI特征,采用多变量逻辑回归确定预测因子,Kaplan-Meier曲线估计DFS。
关键影像表现/征象
- 肿瘤大小与TIL独立相关(OR 1.040,95%CI 1.006–1.075,p=0.020)。
- ADC与TIL独立相关(OR 1.003,95%CI 1.001–1.005,p=0.015)。
- 临床腋窝淋巴结状态与TIL独立相关(OR 3.222,95%CI 1.372–7.568,p=0.007)。
- 强化模式与TIL独立相关(OR 0.284,95%CI 0.143–0.563,p<0.001)。
诊断标准与关键数值
- TIL分组阈值:高TIL为≥10%,低TIL为<10%。
- ALSE模型构成:A为ADC,L为临床腋窝淋巴结状态,S为肿瘤大小,E为强化模式。
临床应用与阅片要点
- 可依据肿瘤大小、ADC值、临床腋窝淋巴结状态和强化模式综合评估TIL水平。
- 高TIL(≥10%)与更好DFS相关(p=0.016),尤其在HER2阳性和三阴性乳腺癌中。
局限性
- 本研究为回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To develop a simple and convenient method based on multiparametric magnetic resonance imaging (MRI) and clinical features to non-invasively predict tumour-infiltrating lymphocytes (TILs) in breast cancer (BC) and to explore the relationship between TIL levels and disease-free survival (DFS).
MATERIALS AND METHODS: A total of 172 BC patients were enrolled between November 2017 and June 2021 in this retrospective study. The patients were divided into high (≥10%) and low (<10%) TIL groups. Clinicopathological data were collected. MRI features were reviewed by two radiologists. Predictors associated with TILs were determined by using multivariable logistic regression analyses. Kaplan-Meier survival curves based on TIL levels were used to estimate DFS.
RESULTS: A total of 102 patients with low TILs and 70 patients with high TILs were included in the study. Tumour size (odds ratio [OR], 1.040; 95% confidence interval [CI]: 1.006, 1.075; p=0.020), apparent diffusion coefficient (ADC; OR, 1.003; 95% CI: 1.001, 1.005; p=0.015), clinical axillary lymph node status (CALNS; OR, 3.222; 95% CI: 1.372,7.568; p=0.007), and enhancement pattern (OR, 0.284; 95% CI: 0.143, 0.563; p<0.001) were independently associated with TIL levels. These features were used in the ALSE model (where A is ADC, L is CALNS, S is size, and E is enhancement pattern). High TILs were associated with better DFS (p=0.016).
CONCLUSION: The ALSE model derived from multiparametric MRI and clinical features could non-invasively predict TIL levels in BC, and high TILs were associated with longer DFS, especially in human epidermal growth factor receptor 2 (HER2)-positive BC and triple-negative BC (TNBC).
引用
- Chen S, Sui Y, Ding S, et al. A simple and convenient model combining multiparametric MRI and clinical features to predict tumour-infiltrating lymphocytes in breast cancer. Clin Radiol. 2023. PMID: 37813758. doi:10.1016/j.crad.2023.08.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。